Genprex Inc. is facing regulatory challenges related to its continued listing on the Nasdaq Capital Market. The company has been notified by the Nasdaq Hearings Panel that it has until October 31, 2025, to regain compliance with the $1.00 minimum bid price requirement and the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1). Genprex has indicated that it may need to raise additional capital to meet these requirements, but there is no assurance that such financing will be available or sufficient to resolve the deficiencies. Failure to comply with these rules could result in the delisting of Genprex's common stock from Nasdaq.
@daz999999999：$Genprex, Inc.(GNPX)$ The Genprex Inc. stock price fell by -4.53% on the last day (Wednesday, 17th Dec 2025) from $2.43 to $2.32. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 6.52% from a day low at $2.30 to a day high of $2.45. The price has fallen in 6 of the last 10 days and is down by -18.02% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -168 thousand shares and in total, 83 thousand shares were bought and sold for approximately $191.50 thousand. Given the current short-term trend, the stock is expected to rise 30.96% during the next 3 months and, with a 90% probability hold a price between $3.04 and $17.72 at the end of this 3-month period. GNPX Signals & Forecast Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Genprex Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.86 and $3.77. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, October 21, 2025, and so far it has fallen -79.83%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. Support, Risk & Stop-loss for Genprex Inc. stock There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days. This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.150 between high and low, or 6.52%. For the last week the stock has had daily average volatility of 12.10%. Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set. Trading Expectations (GNPX) For The Upcoming Trading Day Of Thursday 18th For the upcoming trading day on Thursday, 18th we expect Genprex Inc. to open at $2.36, and during the day (based on 14 day Average True Range), to move between $2.09 and $2.55, which gives a possible trading interval of +/-$0.456 (+/-21.81%) up or down from last closing price. If Genprex Inc. takes out the full calculated possible swing range there will be an estimated 21.81% move between the lowest and the highest trading price during the day. With no support below and resistance from accumulated volume @ $2.43, some $0.110 (4.74%) from the current price of $2.32, our system finds the risk reward not very attractive. Insider sentiment for Genprex Inc. (GNPX) is Positive, fueled by high-impact open-market purchases from insiders. This confidence appears to be a broad consensus, with 8 different insiders buying. Over the last year, insiders have collectively bought or received $133.7K worth of shares and sold $50.3K across 100 transactions. However, focusing on high-impact open-market transactions, insiders purchased $207.5K and sold $0 worth of Genprex Inc. stocks. The most recent trade was made 172 days ago by Berger Mark Stanley (Chief Medical Officer), who used to pay shares worth approximately $1K. The overall evaluation results in a strongly positive Insider Power Score, as the system found the trades or insider related actions from key insiders to be more positive than negative. Is Genprex Inc. stock A Buy? The Genprex Inc. stock holds several positive signals and despite the very positive trend, we believe Genprex Inc. will perform favorably, in the next couple of days or weeks. Therefore, we hold a positive evaluation of this stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments